BIIB Competitors & Alternatives
Compare Biogen Inc. Common Stock with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
BIIB
Main Stock$177.79
Tradestie Score
57
Market Cap
$22.61B
P/E Ratio
20.8
Revenue Growth
-0.1%
Analyst Upside
+15.8%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$349.63
|
$160.70B | 24.8 | 61 | Compare |
|
GILD
Gilead Sciences Inc
|
$140.01
|
$137.92B | 20.6 | 54 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$748.76
|
$46.96B | 37.3 | 55 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$88.75
|
$24.57B | - | 56 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$131.91
|
$13.59B | 28.2 | 65 | Compare |
|
EXEL
Exelixis Inc
|
$43.40
|
$11.09B | 15.8 | 64 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$49.30
|
$10.74B | - | 56 | Compare |
|
QGEN
QIAGEN N.V.
|
$40.22
|
$10.04B | 19.6 | 63 | Compare |
|
TECH
Bio-Techne Corp.
|
$53.08
|
$9.33B | 98.6 | 62 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$64.54
|
$8.77B | 25.2 | 67 | Compare |
More BIIB Analysis
Data updated: Apr 02, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry